Cannabis stocks in 2022: Top trends for investors to watch
What to watch next
Can harsh U.S. economic sanctions deter Russia from invading Ukraine?
CNBC
Pollster Frank Luntz says inflation has become the voting issue of 2022
CNBC
Watch CNBC’s full interview with Loup Ventures Gene Munster
CNBC
Young digital artists are shaking up the art world in the NFT space
CNBC
Restaurant demand remains high but labor supply low, says Kevin Brown
CNBC
Retail sales fall 1.9% in December, far higher than estimates
CNBC
The Pre-Markets Rundown: January 14, 2022
CNBC
JPMorgan Chase, Wells Fargo beat Wall Street’s Q4 earnings estimates
CNBC
Sen. Bernie Sanders asks Blackrock’s Fink to step in and stop coal mine protest in Alabama
CNBC
Tennis star Novak Djokovic is back on the court after an Australian judge revoked his visa cancellation
CNBC
Delta Air Lines beats earnings estimates, forecasts strong spring and summer travel
CNBC
‘We don’t see business travel coming back at all to pre-pandemic levels,’ says Cowen’s Becker
CNBC
Jack Dorsey creates Bitcoin Legal Defense Fund
CNBC
Markets set for positive open ahead of bank earnings
CNBC
2022 ‘Halftime’ Investment Cmte. Stock Summit: Karen Firestone’s picks ADSK, HQY, CME & XLK
CNBC
Wells Fargo, Coinbase, and Google are some of today’s top picks: Pro Market Movers Jan. 14
CNBC
UP NEXT
Brand building may be the central theme in cannabis for 2022, portfolio manager Tim Seymour says.
After a disappointing 2021 on the legislative front, larger players will use this year to bolster their presence in existing cannabis markets and adjacent industries, Seymour told CNBC’s “ETF Edge” this week.
“As we look forward to 2022, one of the big themes for cannabis investors should be the emergence of the brands,” said Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS).
Tilray CEO Irwin Simon told CNBC this week that his company would take a two-pronged approach to business while legislation hangs in the balance: focusing on countries where the substance is federally legal and developing brands in cannabis-adjacent markets.
“What do you do in the U.S. while you wait for legalization? You build out brands and categories with adjacency to the cannabis industry like the spirits business, like the beer business, like the food and hemp business,” Simon said on “Closing Bell.”
“Ultimately, one day, you will see a beer out there with THC. You will see a bourbon out there with THC. You will see edibles. And we have the brands … that consumers will be aware of.”
This targeted approach should help “insulate” publicly traded cannabis companies against margin pressures after a difficult 2021 in which cannabis ETFs declined between 20 and 40%, said Seymour, who is also founder and chief investment officer of Seymour Asset Management and a CNBC contributor.
“If you think about valuations for the sector, we come into 2022 cheaper than we went into 2021,” Seymour said. “This is a sector that offers higher growth than many other sectors outside of cannabis at much lower valuations.”
It’s no surprise that Seymour’s favorite way to invest in the rapidly evolving space is via his actively managed exchange-traded fund, which he says offers necessary diversification and agility.
“For investors that want to be exposed to this industry that’s changing by the day, in an active ETF strategy, you have the ability to quickly adapt,” he said.
CNBS was the second-best performing cannabis ETF in 2021, second only to Cambria’s Cannabis ETF (TOKE), which is roughly one-third of its size.
Seymour credited his fund’s resilience to owning a global portfolio and to an explosion in the cannabis debt markets that allowed companies such as Green Thumb Industries to issue new types of debt instruments that can help guard against downside during periods of volatility.
Recent Comments